Produced by the liver, corticosteroid-binding globulin (CBG) regulates the plasma distribution and actions of glucocorticoids.…
sciencecityDecember 5, 2023
Launched in 2011, the Forbes “30 Under 30” recognizes people under the age of 30…
sciencecityDecember 4, 2023
Dr. Kayla King (Departments of Zoology, Microbiology & Immunology; LSI) has been appointed the Canada…
sciencecityDecember 1, 2023
adMare BioInnovations (adMare) is pleased to welcome 22 life sciences leaders to Cohort VI of…
sciencecityDecember 1, 2023
Congratulations to Amrita Verma, a PhD student in Dr. Neil Cashman’s lab, who is one of…
sciencecityNovember 30, 2023
UBC Faculty of Medicine researchers at the BC Children’s Hospital Research Institute (BCCHR) have made…
sciencecityNovember 29, 2023
Derm-Biome Pharmaceuticals Inc, a Vancouver based biopharmaceutical company with a focus on skin disease, is excited to announce…
Gordon EberweinNovember 29, 2023
After Carl Hansen co-founded AbCellera Biologics Ltd. in 2012, people constantly told him he was…
eabramovichJanuary 13, 2021
Gene expression analysis of pancreatic ductal adenocarcinoma (PDAC) tumours enables clinicians to stratify patients into molecular…
eabramovichJanuary 12, 2021
A pilot study has shown that an experimental vaccine for cat allergy can reduce the…
eabramovichJanuary 11, 2021
Have you ever wondered how your body knows to respond to an infection appropriately? When…
eabramovichJanuary 11, 2021
Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce that it is…
eabramovichJanuary 8, 2021
A Burnaby biotech company is partnering with a global pharmaceutical giant on research into advancing…
eabramovichJanuary 7, 2021
iCo Therapeutics (“iCo” or the “Company”) (TSX-V: ICO) (OTCQB: ICOTF), iCo Therapeutics, Inc. (“iCo”) and…
eabramovichJanuary 6, 2021
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225,…
eabramovichDecember 18, 2020
